We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

VolitionRX Ltd (VNRX) USD0.001

Sell:$0.78 Buy:$0.82 Change: $0.05 (5.88%)
Market closed |  Prices as at close on 24 April 2024 | Switch to live prices |
Sell:$0.78
Buy:$0.82
Change: $0.05 (5.88%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 24 April 2024 | Switch to live prices |
Sell:$0.78
Buy:$0.82
Change: $0.05 (5.88%)
Market closed |  Prices as at close on 24 April 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.

Contact details

Address:
1489 West Warm Springs Road, Suite 110
HENDERSON
89014
United States
Telephone:
+1 (646) 6501351
Website:
https://volition.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
VNRX
ISIN:
US9286611077
Market cap:
$69.76 million
Shares in issue:
82.07 million
Sector:
Health Care Supplies
Exchange:
-
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Martin Faulkes
    Executive Chairman of the Board
  • Cameron Reynolds
    President, Chief Executive Officer, Director
  • Terig Hughes
    Chief Financial Officer, Treasurer
  • Salvatore Butera
    Chief Executive Officer of Volition Vet
  • Jasmine Kway
    Chief Executive Officer of Singapore Volition
  • Gaetan Michel
    Chief Operating Officer
  • Louise Batchelor
    Group Chief Marketing and Communications Officer
  • Jacob Micallef
    Chief Scientific Officer
  • Nicholas Plummer
    Group General Counsel
  • Gael Forterre
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.